Today, the Office of the U.S. Trade Representative (USTR) announced that it will extend Section 301 tariff exclusions on medical products used to treat COVID-19 for an additional 90 days.

The 81 exclusions were originally set to expire on November 30, 2022; however, the exclusions will now apply to products meeting the specified criteria until February 28, 2023.

Click here to view the Federal Register Notice.

All importers who have an eligible product are able to claim an exemption under the exclusions, regardless of whether the importer filed an exclusion request. It is possible the USTR will continue to issue decisions on pending exclusion requests on a periodic basis.

As always, we encourage you to contact our compliance experts with any questions or for assistance with the exclusion process.

Shapiro will also continue to monitor and provide status updates on our Section 301 Tariff News page as they become available.